share_log

Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)

Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)

極光大麻 | 6-K:外國發行人報告(業績相關)
美股SEC公告 ·  2024/07/29 06:44

Moomoo AI 已提取核心訊息

Aurora Cannabis Inc. has announced its Q1 2025 investor conference call, scheduled for August 7, 2024, at 8:00 a.m. Eastern Time. The company will release its financial results for the quarter ended June 30, 2024, before markets open on the same day. CEO Miguel Martin and CFO Simona King will host the call and Q&A session.Aurora Cannabis, headquartered in Edmonton, Alberta, is a global medical cannabis company serving markets across Canada, Europe, Australia, and South America. The company's portfolio includes adult-use brands like Aurora Drift and San Rafael '71, as well as medical cannabis brands such as MedReleaf and CanniMed. Aurora also holds a controlling stake in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants.The announcement includes forward-looking statements, cautioning investors about potential risks and uncertainties that could cause actual results to differ from projections. These risks include factors affecting personnel retention, infrastructure investment, financing, product quality, and regulatory changes.
Aurora Cannabis Inc. has announced its Q1 2025 investor conference call, scheduled for August 7, 2024, at 8:00 a.m. Eastern Time. The company will release its financial results for the quarter ended June 30, 2024, before markets open on the same day. CEO Miguel Martin and CFO Simona King will host the call and Q&A session.Aurora Cannabis, headquartered in Edmonton, Alberta, is a global medical cannabis company serving markets across Canada, Europe, Australia, and South America. The company's portfolio includes adult-use brands like Aurora Drift and San Rafael '71, as well as medical cannabis brands such as MedReleaf and CanniMed. Aurora also holds a controlling stake in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants.The announcement includes forward-looking statements, cautioning investors about potential risks and uncertainties that could cause actual results to differ from projections. These risks include factors affecting personnel retention, infrastructure investment, financing, product quality, and regulatory changes.
Aurora大麻股公司已宣佈其2025年第一季度投資者看漲會議電話,定於2024年8月7日上午8:00(東部時間)舉行。該公司將在同一天市場開盤前發佈截至2024年6月30日的季度財務業績。CEO米格爾·馬丁(Miguel Martin)和CFO西蒙娜·金(Simona King)將主持此次電話會議和問答環節。Aurora大麻股總部位於亞伯塔省埃德蒙頓,是一家全球醫療大麻公司,服務於加拿大、歐洲、澳洲和南美市場。該公司的產品組合包括成人消費品牌如Aurora Drift和San Rafael '71,以及醫療大麻品牌如MedReleaf和CanniMed。Aurora還持有Bevo Farms Ltd.的控股權,後者是北美領先的繁殖農產品供應商。該公告包括前瞻性聲明,提醒投資者潛在的風險和不確定性,這些因素可能導致實際結果與預測有所不同。這些風險包括影響人員留用、製造行業投資、融資、產品質量和監管變化的因素。
Aurora大麻股公司已宣佈其2025年第一季度投資者看漲會議電話,定於2024年8月7日上午8:00(東部時間)舉行。該公司將在同一天市場開盤前發佈截至2024年6月30日的季度財務業績。CEO米格爾·馬丁(Miguel Martin)和CFO西蒙娜·金(Simona King)將主持此次電話會議和問答環節。Aurora大麻股總部位於亞伯塔省埃德蒙頓,是一家全球醫療大麻公司,服務於加拿大、歐洲、澳洲和南美市場。該公司的產品組合包括成人消費品牌如Aurora Drift和San Rafael '71,以及醫療大麻品牌如MedReleaf和CanniMed。Aurora還持有Bevo Farms Ltd.的控股權,後者是北美領先的繁殖農產品供應商。該公告包括前瞻性聲明,提醒投資者潛在的風險和不確定性,這些因素可能導致實際結果與預測有所不同。這些風險包括影響人員留用、製造行業投資、融資、產品質量和監管變化的因素。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息